Lori Lawley
Financieel Directeur/CFO bij LUMOS PHARMA, INC.
Vermogen: 34 536 $ op 30-04-2024
Actieve functies van Lori Lawley
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LUMOS PHARMA, INC. | Bedrijfssecretaris | 01-03-2020 | - |
Financieel Directeur/CFO | 04-07-2021 | - | |
Comptroller/Controller/Auditor | 01-03-2020 | - |
Loopbaan van Lori Lawley
Eerdere bekende functies van Lori Lawley
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LUMOS PHARMA, INC. | Comptroller/Controller/Auditor | 26-07-2018 | 01-03-2020 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-10-2014 | 01-04-2015 |
Opleiding van Lori Lawley
McCombs School of Business | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
2 |
Operationeel
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 1 |
Corporate Secretary | 1 |
Sectoraal
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
LUMOS PHARMA, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
NewLink Genetics Corp.
NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
- Beurs
- Insiders
- Lori Lawley
- Ervaring